Tag - pharmaceutical

 
 

PHARMACEUTICAL

Kobayashi Pharmaceutical President Akihiro Kobayashi (second from left) and other executives apologize for the deaths and other health damage associated with its dietary supplements, in the city of Osaka on Friday.
JAPAN / Science & Health
Mar 29, 2024
Kobayashi Pharma says blue mold compound may be cause of health problems
The beni kо̄ji red yeast rice dietary supplements are now linked to five deaths and 114 hospitalizations.
Packs of dietary supplements designated as functional food by Kobayashi Pharmaceutical. Consumer rights groups have for years argued that the functional food label is thin in scientific evidence and potentially harmful to health.
JAPAN / Science & Health
Mar 29, 2024
Kobayashi Pharma scandal reignites debate on ‘functional food’ labels
The labels have been criticized for years over the lack of sufficient scientific proof of safety and efficacy accompanying their use.
According to Yano Research Institute, Japan's supplements market grew about 30% in the span of three years.
BUSINESS
Mar 29, 2024
Supplements market in Japan showing steady growth
Improved health awareness sparked by COVID-19 is a major factor fueling the growth, market research firms say.
An official from the city government's health department in Kahosiung, Taiwan, checks the shelves at a drugstore in the city on Wednesday regarding Kobayashi Pharmaceutical's products.
JAPAN
Mar 29, 2024
Kobayashi Pharma confirms fifth death linked to its supplements
The relationship between the deaths and the supplements remains unclear.
Kobayashi Pharmaceutical's Osaka manufacturing facility in the city of Osaka on Wednesday
JAPAN / Science & Health / EXPLAINER
Mar 28, 2024
What we know so far about Kobayashi Pharma's supplement deaths
The Osaka-based drugmaker is finding itself under further scrutiny as the search to pinpoint the cause of the deaths continues.
Kobayashi Pharmaceutical holds its annual shareholders meeting on Thursday in Osaka.
JAPAN / Science & Health
Mar 28, 2024
Two more deaths linked to Kobayashi Pharma's red yeast supplements
The company has voluntarily recalled five of its products, including about 300,000 packages of its Beni Koji Choleste Help supplements.
Kobayashi Pharmaceutical has announced a recall of its products.
JAPAN / Science & Health
Mar 27, 2024
Concerns mount after two deaths linked to Kobayashi Pharma supplement
A government probe is being conducted to establish whether the supplement, which contains beni kо̄ji red fermented rice, led to the deaths.
Kobayashi Pharmaceutical is voluntarily recalling products containing beni kōji, including Beni Koji Choleste Help supplements.
JAPAN / Science & Health
Mar 26, 2024
One dead after consuming Kobayashi Pharma's health supplements
The Osaka-based drugmaker is probing the incident to determine any causal link between the product's consumption and the individual's death.
Kobayashi Pharmaceutical is voluntarily recalling five products, including about 300,000 packages of Beni Koji Choleste Help
JAPAN / Science & Health
Mar 25, 2024
26 hospitalized after taking Kobayashi Pharma's health supplements
The company confirmed 20 additional hospitalizations by Sunday through a consultation line established over reports of kidney and other health problems.
Akihiro Kobayashi (left), president of major drugmaker Kobayashi Pharmaceutical, speaks to reporters along with other executives in Osaka on Friday.
JAPAN / Science & Health
Mar 24, 2024
Osaka drugmaker recalls dietary supplements linked to kidney disorders
The Osaka-based drugmaker announced Friday that, of the six hospitalized, two suffered symptoms serious enough to require temporary dialysis.
Toshiba went private through a takeover bid after a series of battles with activist shareholders.
BUSINESS / Companies
Jan 21, 2024
Management buyouts by big companies on rise in Japan
The total value of management buyout deals exceeded ¥1.4 trillion in Japan in 2023 to hit a record high.
Buyouts by management and controlling parties have surged this year in Japan, with the total value now set to pass ¥1 trillion.
COMMENTARY / Japan
Dec 3, 2023
Being a listed company in Japan is losing its luster
Japan's corporate landscape is shifting as companies opt for management buyouts.
Japan Times
BUSINESS
Nov 12, 2022
Takeda to seek Japan approval for dengue vaccine
The firm's CEO said Takeda will prioritize regulatory approval in endemic countries, and that it will later seek approval in Japan to make it available for travelers.
Japan Times
ASIA PACIFIC
Apr 23, 2022
Questions over effectiveness of COVID remedy costs top Chinese scientist $2 billion
Debate over the efficacy of traditional Chinese medicine has intensified in recent weeks as the nation fights its worst outbreak since the early days of the pandemic.
Japan Times
BUSINESS
Dec 13, 2021
Billionaire’s bet on Pfizer vaccine for China fails to pay off
Xi Jinping's administration has backed a nationalist agenda on all fronts, including in the fight against the virus.
Japan Times
JAPAN
Oct 1, 2021
Japan's Takeda says 'human error' caused contamination of Moderna vaccines
Japanese authorities in August suspended the use of three batches of Moderna shots containing 1.63 million doses after being notified of the contamination.
Japan Times
BUSINESS / Companies
Oct 22, 2020
Fujifilm works with Shanghai firm to get Avigan approved in China
Fujifilm Holdings Corp. said on Thursday it has partnered with Shanghai-based Carelink Pharmaceutical Co. to seek approval in China for Avigan to treat COVID-19 and influenza.
Japan Times
COMMENTARY / World
Aug 26, 2020
Pharma rivals are fighting COVID-19 together — Why stop there?
Pandemics make for strange bedfellows.
Japan Times
BUSINESS / Companies
Jul 31, 2020
Taisho emerges as lead bidder for Takeda $3 billion consumer unit
Taisho Pharmaceutical Holdings Co. has emerged as the leading contender to acquire Takeda Pharmaceutical Co.’s Japanese consumer health care business, according to people familiar with the matter.
Japan Times
ASIA PACIFIC / Science & Health
May 13, 2020
A tale of two Japanese drugs in tests to fight COVID-19
Avigan and camostat are undergoing trials as they may be effective in treating illnesses brought on by coronavirus.

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'